SYNBIOTICS REVENUES FALL, LOSS DEEPENSSynbiotics Corp. (NASDAQ:SBIO) of San Diego.
Third quarter ended Dec. 31
(Figures in thousands except per-share data.)
1990 1989
Revenues $1,822 2,570Net income (loss) (1,646) (556)Net income per share (loss) (.33) (.11)Outstanding shares 5,016 5,001
TEVA PHARMACEUTICALS INCREASES REVENUES, EARNINGS
Teva Pharmaceuticals of Israel
Third quarter ended Dec. 31
(Figures in thousands except per-share data.)
1990 1989
Revenues $302,253 274,930Net income (loss) 19,096 16,508Net income per share (loss) .81 .73
Amounts converted from Israeli shekels; 1 shekel equals $.50U.S.
(c) 1997 American Health Consultants. All rights reserved.